人参总次苷调控PGC1α信号通路改善心梗后大鼠心肌能量代谢OA
Regulation of PGC1α Signaling Pathway by Total Secondary Ginsenosides to Improve Myocardial Energy Metabolism in Post-Myocardial Infarction Rats
目的:探讨人参总次苷通过调节过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC1α)信号通路对心梗后大鼠心肌能量代谢的影响和潜在机制.方法:选取100 只SD大鼠行冠状动脉左前降支结扎术建立心肌梗死模型,心电图观察大鼠造模成功后,随机分为模型对照组、人参总次苷 11.6、23.3 mg/kg 组、辅酶 Q10 10 mg/kg组,假手术对照组在冠状动脉左前降支下仅穿线不结扎.各组灌胃给予相应药物,治疗 4 w.HE染色和Masson染色观察心肌组织损伤;比色法试剂盒检测心肌羟脯氨酸(HYP)、三磷酸腺苷(ATP)、二磷酸腺苷(ADP)、一磷酸腺苷(AMP)含量;流式细胞仪检测心肌线粒体膜电位水平;实时荧光定量法(RT-PCR)检测心肌线粒体转录因子A(Tfam)、Pgc1α、雌激素相关受体α(Errα)、核呼吸因子 1(Nrf1)、核呼吸因子 2(Nrf2)、过氧化物酶体增殖物激活受体α(Pparα)mRNA表达;Western blot法检测心肌钠-钾-ATP酶(Na+-K+-ATPase)、解偶联蛋白2(UCP2)、腺苷酸转位酶(ANT)、TFAM、PGC-1α、ERRα、NRF-1、NRF-2、PPARα的蛋白表达.结果:与假手术对照组比较,心梗造模组大鼠的心电图ST段抬高幅度显著增加(P<0.01),提示心肌梗死模型造模成功,模型对照组大鼠心肌组织损伤明显加重,胶原容积分数、心肌HYP含量显著升高(P<0.01),ATP含量明显降低,ADP 和AMP含量显著升高(P<0.01),ANT和Na+-K+-ATPase蛋白表达下调、UCP2 蛋白表达上调(P<0.01),心肌线粒体膜电位显著下降(P<0.01),心肌 Tfam、Pgc1α、Errα、Nrf1、Nrf2、Pparα 的 mRNA 与蛋白表达显著下调(P<0.01);与模型对照组比较,人参总次苷11.65、23.3 mg/kg组和辅酶Q1010 mg/kg组心肌组织损伤明显减轻,胶原容积分数、HYP含量显著下降(P<0.01),心肌ATP含量显著升高,ADP和AMP含量显著下降(P<0.01),人参总次苷11.6 mg/kg组ANT蛋白表达上调,UCP2 蛋白表达下调(P<0.01),线粒体膜电位明显升高(P<0.01),TFAM的蛋白表达上调(P<0.01),Pgc1α、Errα、Nrf1、Nrf2、Pparα的mRNA和蛋白表达明显上调(P<0.05 或P<0.01),人参总次苷23.3 mg/kg组和辅酶Q1010 mg/kg组Na+-K+-ATPas和ANT蛋白表达上调,UCP2 蛋白表达下调(P<0.01),线粒体膜电位明显升高(P<0.01),Tfam、Pgc1α、Errα、Nrf1、Nrf2、Pparα的mRNA和蛋白表达均显著上调(P<0.01).结论:人参总次苷可改善心梗后心肌损伤,平衡心肌高能磷酸盐代谢及相关转运蛋白的表达,提高心肌线粒体膜电位水平,具有改善心肌能量代谢的作用,其作用机制可能与提高PGC1α信号通路相关因子表达有关.
Objective:To investigate the effect of total secondary ginsenosides on improving myocardial energy me-tabolism in post-myocardial infarction rats by regulating peroxisome proliferator-activated receptor-gamma coactivator 1α(PGC1α)signaling pathway and explore its underlying mechanism.Methods:A total of 100 SD rats were selected and underwent ligation of the anterior descending branch of the left coronary artery to establish a myocardial infarction model.The rats were randomly divided into five groups:normal control group,model control group,groups receiving total second-ary ginsenosides at doses of 11.6 and 23.3 mg/kg(TSG-L and TSG-H groups),and coenzyme Q10 group(10 mg/kg).Each group was given the corresponding drugs by gavage for four weeks.Myocardial tissue injury was observed by hema-toxylin-eosin(HE)staining and Masson's trichrome staining.The contents of hydroxyproline(HYP),adenosine triphosphate(ATP),adenosine diphosphate(ADP),and adenosine monophosphate(AMP)in the myocardium were de-tected using colorimetric assay kits.The mitochondrial membrane potential of the myocardium was detected by flow cy-tometry.The mRNA expression levels of mitochondrial transcription factor A(Tfam),PGC1α,estrogen-related receptor α(Errα),nuclear respiratory factor 1(Nrf1),nuclear respiratory factor 2(Nrf2),and peroxisome proliferator-activated receptor alpha(Pparα)in myocardium were detected by real-time PCR(RT-PCR).Protein expression levels of Na+-K+-ATPase,uncoupling protein 2(UCP2),adenine nucleotide translocator(ANT),TFAM,PGC-1α,ERRα,NRF-1,NRF-2,and PPARα were detected by Western Blot.Results:Compared with that in the normal control group,the myo-cardial tissue damage in the model control group was significantly aggravated,while collagen volume fraction and HYP content were increased significantly(P<0.01),accompanied by significantly decreased ATP content and markedly in-creased ADP and AMP levels(P<0.01).The protein expression of ANT and Na+-K+-ATPase was downregulated,while that of UCP2 was upregulated(P<0.01).The mitochondrial membrane potential of the myocardium was significantly re-duced,and both protein and mRNA expression levels of TFAM,PGC-1α,ERRα,NRF-1,NRF-2,and PPARα were signif-icantly downregulated(P<0.01).Compared with the model control group,groups treated with total secondary ginsen-osides(11.65 and 23.3 mg/kg)and coenzyme Q10(10 mg/kg)exhibited significantly alleviated myocardial tissue damage,markedly reduced collagen volume fraction and HYP content(P<0.01),significantly increased ATP levels,and markedly decreased ADP and AMP levels(P<0.01).In the TSG-L group,the protein expression of ANT was upregulat-ed,while that of UCP2 was downregulated(P<0.01).The mitochondrial membrane potential and TFAM protein levels were significantly increased(P<0.01),and the protein and mRNA expression levels of PGC1α,ERRα,NRF1,NRF2,and PPARα were significantly upregulated(P<0.05 or P<0.01).In the TSG-H and coenzyme Q10 groups,protein ex-pression levels of Na+-K+-ATPase and ANT were upregulated,while UCP2 protein expression was downregulated(P<0.01).Additionally,significant increases were observed in mitochondrial membrane potential and in the protein and mR-NA expression levels of TFAM,PGC1α,ERRα,NRF1,NRF2,and PPARα(P<0.01).Conclusion:Total secondary ginsenosides can improve myocardial injury after myocardial infarction,balance myocardial high-energy phosphate metab-olism and related transporter protein expression,and elevate myocardial mitochondrial membrane potential,thereby impro-ving myocardial energy metabolism.Its mechanism may be related to upregulating the expression of PGC1α signaling pathway-related factors.
李彬;肖悦;李佳;张爱群;朱明军;高尚先;谢世阳;高原;王新陆
河南中医药大学第一附属医院心脏中心,郑州 450000||河南省中医药循证医学中心,郑州 450000上海辉昱生物医药科技有限公司,上海 200000河南中医药大学第一附属医院心脏中心,郑州 450000上海辉昱生物医药科技有限公司,上海 200000河南中医药大学第一附属医院心脏中心,郑州 450000上海辉昱生物医药科技有限公司,上海 200000河南中医药大学第一附属医院心脏中心,郑州 450000河南中医药大学第一附属医院心脏中心,郑州 450000河南中医药大学第一附属医院心脏中心,郑州 450000
人参总次苷心肌梗死过氧化物酶体增殖物激活受体α心肌钠-钾-ATP酶解偶联蛋白2腺苷酸转位酶心肌线粒体转录因子A雌激素相关受体α核呼吸因子
《中药药理与临床》 2026 (1)
68-76,9
国家自然科学基金项目(编号:82074226)河南省中医药科学研究专项(编号:2024ZY2013、2023ZXZX1165、2022JDZX120)河南省科技攻关(编号:222102310332).
评论